Regístrese para obtener acceso a información personalizada con respecto a la marca, las indicaciones regulares del tratamiento que brinda, las pautas de dosificación y recursos tales como los estudios principales, la información para el paciente y videos breves seleccionados conforme a sus intereses especiales.

Xarelto^® Artículos

Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

Autores: Tomasz J.GuzikMD, Chinthanie Ramasundarahettige, Nana Pogosova, Patricio Lopez-Jaramillo, Leanne Dyal, Scott D. Berkowitz, Eva Muehlhofer, Deepak L. Bhatt, Keith A. A. Fox, SalimYusuf, John W. Eikelboom.

Consulte aquí más información

Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial

Autores: Deepak L. Bhatt, John W. Eikelboom, Stuart J. Connolly, P. Gabriel Steg, Sonia S. Anand, Subodh Verma, Kelley R.H. Branch, Jeffrey Probstfield, Jackie Bosch, Olga Shestakovska, Michael Szarek, Aldo Pietro Maggioni, Petr Widimský, Alvaro Avezum, Rafael Diaz, Basil S. Lewis, Scott D. Berkowitz, Keith A.A. Fox, Lars Ryden, Salim Yusuf.

Consulte aquí más información

Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease

Autores: Yan Liang, Jun Zhu, Lisheng Liu, Sonia S Anand, Stuart J Connolly, Jackie Bosch, Tomasz J Guzik, Martin O’Donnell, Gilles R Dagenais, Keith Aa Fox, Olga Shestakovska, Scott D Berkowitz, Eva Muehlhofer, Lars Keller, Salim Yusuf, John W Eikelboom, for the COMPASS Investigators.

Consulte aquí más información

Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)

Autores: Kevin R. Bainey, Robert C. Welsh, Stuart J. Connolly, Tamara Marsden, Jackie Bosch, Keith A.A. Fox, P. Gabriel Steg, Dragos Vinereanu, Derek L. Connolly, Scott D. Berkowitz, JoAnne M. Foody, Jeffrey L. Probstfield, Kelley R. Branch, Basil S. Lewis, Rafael Diaz, Eva Muehlhofer, Petr Widimsky, Salim Yusuf, John W. Eikelboom, Deepak L. Bhatt, and On behalf of the COMPASS Investigators

Consulte aquí más información

Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin

Autores: John W. Eikelboom MBB, Sabc Jacqueline, J. Bosch PhD, Stuart J. Connolly MD, Olga Shestakovska MS, Gilles R. Dagenais MD, Robert G. Hart MD, Darryl P. Leong MBBS, Martin O’ Donnell MBChB, Keith A. A. Fox MBChB, Deepak L. Bhatt MD, MPH John A. Cairns MD, Christoph Tasto PhD, Scott D. Berkowitz MD, Nancy Cook Bruns MD, Eva Muehlhofer MD, Rafael Diaz MD, Aldo P. Maggioni MD, Salim Yusuf DPhil

Consulte aquí más información

Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease

Autores: Kelley R. Branch, Jeffrey L. Probstfield, John W. Eikelboom, Jackie Bosch, Aldo P. Maggioni, Richard K. Cheng, Deepak L. Bhatt, Alvaro Avezum, Keith A.A. Fox, Stuart J. Connolly, Olga Shestakovska, Salim Yusuf

Consulte aquí más información

Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial

Autores: Keith A. A. Fox MBChB, John W. Eikelboom MBBS, Olga Shestakovska MSc, Stuart J. Connolly MD, Kaj P. Metsarinne MD, Salim Yusuf D Phil

Consulte aquí más información

Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial

Autores: Sonia S. Anand MD, PhD, John W. Eikelboom MBBS, MSc, Leanne Dyal MS, Jackie Bosch MSc, PhD Christoph Neumann PhD, Petr Widimsky MD, DSc, Alvaro A. Avezum MD, PhD, Jeffrey Probstfield MD, Nancy Cook Bruns MD, Keith A. A. Fox MBChB, BSc, Deepak L. Bhatt MD, MPH, Stuart J. Connolly MD, Salim Yusuf MBBS, DPhil, COMPASS Trial Investigators.

Consulte aquí más información

GUÍA DE DOSIFICACIÓN

MANEJO PRÁCTICO

INFORMACIÓN PARA PRESCRIBIR

Xarelto^® Artículos

Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial

Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease

Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)

Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin

Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease

Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial

Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial

GUÍA DE DOSIFICACIÓN

MANEJO PRÁCTICO

INFORMACIÓN PARA PRESCRIBIR

Xarelto® Artículos

Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial

Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease

Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)

Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin

Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease

Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial

Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial

Authentication Modal

Por favor selecciona una opción:

Xarelto^® Artículos